title: Group interventions for patients with cancer and HIV disease: Part III. Moderating variables and mechanisms of action.
abstract: Growing evidence supports the value of group interventions for individuals who are at risk for or have developed cancer or HIV disease. However, information is more limited concerning how these services can be delivered in an optimal manner, and what processes contribute to their benefits. Parts I and II of this review examined the efficacy of different interventions for individuals at different phases of illness, ranging from primary prevention to late-stage disease, in both psychosocial and biological domains. The current paper examines some of the factors other than phase of illness that might influence group treatment effects (e.g., intervention parameters, participant characteristics), and explores mechanisms of action.
authors.affiliation: Department of Otolaryngology, University of Arkansas for Medical Sciences, Little Rock 72205, USA. ShermanAllenC@uams.edu
authors.forename: Allen C
authors.initials: AC
authors.lastname: Sherman
authors.forename: Julie
authors.initials: J
authors.lastname: Mosier
authors.forename: Molyn
authors.initials: M
authors.lastname: Leszcz
authors.forename: Gary M
authors.initials: GM
authors.lastname: Burlingame
authors.forename: Kathleen Hubbs
authors.initials: KH
authors.lastname: Ulman
authors.forename: Trish
authors.initials: T
authors.lastname: Cleary
authors.forename: Stephanie
authors.initials: S
authors.lastname: Simonton
authors.forename: Umaira
authors.initials: U
authors.lastname: Latif
authors.forename: Lara
authors.initials: L
authors.lastname: Hazelton
authors.forename: Bernhard
authors.initials: B
authors.lastname: Strauss
mesh_terms: D015658:HIV Infections / Q000150:complications* / Q000523:psychology*; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000523:psychology*; D011615:Psychotherapy, Group / Q000379:methods*; D012944:Social Support